Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.2B | 4.2B | 4.0B | 3.8B |
Cost of revenue | 2.9B | 2.9B | 2.7B | 2.7B |
Gross profit | 1.3B | 1.4B | 1.2B | 1.1B |
Operating expense | ||||
Research & development | 379M | 376M | 342M | 379M |
Selling general and admin | 438M | 515M | 444M | 467M |
Other operating expenses | — | — | — | — |
Operating income | 509M | 477M | 454M | 266M |
Non operating interest income | ||||
Income | 67M | 63M | 61M | 53M |
Expense | 8M | 9M | 9M | 9M |
Other income expense | -238M | -34M | -111M | -43M |
Pretax income | 328M | 499M | 398M | 270M |
Tax provision | 103M | 132M | 98M | -4M |
Net income | 225M | 367M | 300M | 274M |
Basic EPS | 1.1 | 1.8 | 1.5 | 1.4 |
Diluted EPS | 1.1 | 1.8 | 1.5 | 1.3 |
Basic average shares | 204.5M | 202.9M | 201.6M | 200.0M |
Diluted average shares | 210.2M | 209.0M | 207.4M | 206.1M |
EBITDA | 601M | 572M | 548M | 352M |
Net income from continuing op. | 225M | 367M | 300M | 274M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |